(MORN) Morningstar - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6177001095

Investment Data, Research, Analytics, Credit Ratings, Indexes

MORN EPS (Earnings per Share)

EPS (Earnings per Share) of MORN over the last years for every Quarter: "2020-09": 1.55, "2020-12": 1.57, "2021-03": 1.73, "2021-06": 1.76, "2021-09": 1.38, "2021-12": 1.29, "2022-03": 1.41, "2022-06": 1.17, "2022-09": 0.77, "2022-12": 0.58, "2023-03": -0.56, "2023-06": 1.6, "2023-09": 1.28, "2023-12": 1.7093, "2024-03": 1.493, "2024-06": 1.6032, "2024-09": 2, "2024-12": 2.7123, "2025-03": 2.23, "2025-06": 2.4, "2025-09": 0,

MORN Revenue

Revenue of MORN over the last years for every Quarter: 2020-09: 357.2, 2020-12: 380.4, 2021-03: 392.8, 2021-06: 415.4, 2021-09: 428.9, 2021-12: 462.2, 2022-03: 457, 2022-06: 470.4, 2022-09: 468.2, 2022-12: 475, 2023-03: 479.7, 2023-06: 504.7, 2023-09: 515.5, 2023-12: 542.4, 2024-03: 544, 2024-06: 570.5, 2024-09: 569.4, 2024-12: 591, 2025-03: 581.9, 2025-06: 605.1, 2025-09: null,

Description: MORN Morningstar

Morningstar Inc (NASDAQ:MORN) is a leading provider of independent investment insights and data analytics, operating globally across multiple segments, including data and analytics, wealth management, credit ratings, and retirement services. The companys diverse product portfolio includes managed investments, research platforms, and credit analytics solutions, catering to a wide range of clients, from financial advisors to institutional investors.

Key performance indicators (KPIs) that highlight MORNs financial health and operational efficiency include its revenue growth, operating margins, and return on equity (RoE). With a RoE of 24.68%, MORN demonstrates a strong ability to generate profits from shareholder equity. Additionally, the companys diversified revenue streams, including subscription-based services and asset-based fees, contribute to its financial stability. The companys PitchBook and Morningstar Sustainalytics segments have shown significant growth potential, driven by increasing demand for private market data and ESG (Environmental, Social, and Governance) research.

MORNs competitive advantage lies in its comprehensive data and analytics capabilities, which enable clients to make informed investment decisions. The companys brand recognition, extensive research coverage, and high-quality data products have fostered strong relationships with clients and created a loyal customer base. Furthermore, MORNs commitment to independence and objectivity has earned it a reputation as a trusted provider of investment insights.

To evaluate MORNs future prospects, key metrics to monitor include revenue growth, operating margin expansion, and the companys ability to innovate and expand its product offerings. The increasing demand for ESG investing and alternative data is expected to drive growth in MORNs Sustainalytics and PitchBook segments. Additionally, the companys investments in digital transformation and data analytics are likely to enhance its operational efficiency and client value proposition.

MORN Stock Overview

Market Cap in USD 9,543m
Sub-Industry Financial Exchanges & Data
IPO / Inception 2005-05-03

MORN Stock Ratings

Growth Rating -23.0%
Fundamental 85.0%
Dividend Rating 48.0%
Return 12m vs S&P 500 -42.3%
Analyst Rating 4.0 of 5

MORN Dividends

Dividend Yield 12m 0.81%
Yield on Cost 5y 1.02%
Annual Growth 5y 1.69%
Payout Consistency 95.9%
Payout Ratio 19.5%

MORN Growth Ratios

Growth Correlation 3m -94%
Growth Correlation 12m -88.8%
Growth Correlation 5y 50.2%
CAGR 5y 1.27%
CAGR/Max DD 3y (Calmar Ratio) 0.03
CAGR/Mean DD 3y (Pain Ratio) 0.12
Sharpe Ratio 12m -0.52
Alpha -48.54
Beta 1.000
Volatility 22.22%
Current Volume 279k
Average Volume 20d 432.1k
Stop Loss 218.3 (-3%)
Signal -0.52

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (404.1m TTM) > 0 and > 6% of Revenue (6% = 140.8m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA -0.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 5.17% (prev 1.77%; Δ 3.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.15 (>3.0%) and CFO 535.3m > Net Income 404.1m (YES >=105%, WARN >=100%)
Net Debt (530.5m) to EBITDA (755.8m) ratio: 0.70 <= 3.0 (WARN <= 3.5)
Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (42.8m) change vs 12m ago -0.70% (target <= -2.0% for YES)
Gross Margin 60.94% (prev 54.34%; Δ 6.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 66.74% (prev 63.83%; Δ 2.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 13.47 (EBITDA TTM 755.8m / Interest Expense TTM 42.0m) >= 6 (WARN >= 3)

Altman Z'' 4.16

(A) 0.03 = (Total Current Assets 1.04b - Total Current Liabilities 921.0m) / Total Assets 3.63b
(B) 0.56 = Retained Earnings (Balance) 2.04b / Total Assets 3.63b
(C) 0.16 = EBIT TTM 565.9m / Avg Total Assets 3.52b
(D) 0.98 = Book Value of Equity 1.98b / Total Liabilities 2.02b
Total Rating: 4.16 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 85.00

1. Piotroski 6.50pt = 1.50
2. FCF Yield 3.88% = 1.94
3. FCF Margin 16.61% = 4.15
4. Debt/Equity 0.64 = 2.30
5. Debt/Ebitda 0.70 = 2.13
6. ROIC - WACC (= 9.40)% = 11.75
7. RoE 25.22% = 2.10
8. Rev. Trend 98.25% = 7.37
9. EPS Trend 34.95% = 1.75

What is the price of MORN shares?

As of October 15, 2025, the stock is trading at USD 225.07 with a total of 279,033 shares traded.
Over the past week, the price has changed by -0.52%, over one month by -8.55%, over three months by -23.35% and over the past year by -33.84%.

Is Morningstar a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Morningstar (NASDAQ:MORN) is currently (October 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 85.00 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MORN is around 173.55 USD . This means that MORN is currently overvalued and has a potential downside of -22.89%.

Is MORN a buy, sell or hold?

Morningstar has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy MORN.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the MORN price?

Issuer Target Up/Down from current
Wallstreet Target Price 315 40%
Analysts Target Price 315 40%
ValueRay Target Price 194.1 -13.8%

Last update: 2025-10-04 03:56

MORN Fundamental Data Overview

Market Cap USD = 9.54b (9.54b USD * 1.0 USD.USD)
P/E Trailing = 24.0958
P/E Forward = 19.802
P/S = 4.0654
P/B = 5.9109
Beta = 1.0
Revenue TTM = 2.35b USD
EBIT TTM = 565.9m USD
EBITDA TTM = 755.8m USD
Long Term Debt = 838.8m USD (from longTermDebt, last quarter)
Short Term Debt = 39.3m USD (from shortTermDebt, last quarter)
Debt = 1.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 530.5m USD (from netDebt column, last quarter)
Enterprise Value = 10.04b USD (9.54b + Debt 1.03b - CCE 541.6m)
Interest Coverage Ratio = 13.47 (Ebit TTM 565.9m / Interest Expense TTM 42.0m)
FCF Yield = 3.88% (FCF TTM 389.8m / Enterprise Value 10.04b)
FCF Margin = 16.61% (FCF TTM 389.8m / Revenue TTM 2.35b)
Net Margin = 17.21% (Net Income TTM 404.1m / Revenue TTM 2.35b)
Gross Margin = 60.94% ((Revenue TTM 2.35b - Cost of Revenue TTM 916.9m) / Revenue TTM)
Gross Margin QoQ = 61.89% (prev 60.23%)
Tobins Q-Ratio = 2.76 (Enterprise Value 10.04b / Total Assets 3.63b)
Interest Expense / Debt = 1.00% (Interest Expense 10.3m / Debt 1.03b)
Taxrate = 22.58% (26.3m / 116.5m)
NOPAT = 438.1m (EBIT 565.9m * (1 - 22.58%))
Current Ratio = 1.13 (Total Current Assets 1.04b / Total Current Liabilities 921.0m)
Debt / Equity = 0.64 (Debt 1.03b / totalStockholderEquity, last quarter 1.61b)
Debt / EBITDA = 0.70 (Net Debt 530.5m / EBITDA 755.8m)
Debt / FCF = 1.36 (Net Debt 530.5m / FCF TTM 389.8m)
Total Stockholder Equity = 1.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.13% (Net Income 404.1m / Total Assets 3.63b)
RoE = 25.22% (Net Income TTM 404.1m / Total Stockholder Equity 1.60b)
RoCE = 23.19% (EBIT 565.9m / Capital Employed (Equity 1.60b + L.T.Debt 838.8m))
RoIC = 18.23% (NOPAT 438.1m / Invested Capital 2.40b)
WACC = 8.83% (E(9.54b)/V(10.58b) * Re(9.70%) + D(1.03b)/V(10.58b) * Rd(1.00%) * (1-Tc(0.23)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.23%
[DCF Debug] Terminal Value 73.71% ; FCFE base≈389.7m ; Y1≈419.6m ; Y5≈516.3m
Fair Price DCF = 160.7 (DCF Value 6.78b / Shares Outstanding 42.2m; 5y FCF grow 8.65% → 3.0% )
EPS Correlation: 34.95 | EPS CAGR: -19.33% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.25 | Revenue CAGR: 9.78% | SUE: 0.00 | # QB: 0

Additional Sources for MORN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle